Brd202 Venlafaxine Depression For Nervous Assessment Answers

Marketing and Commercial Aspects .In this section, you should describe how you will market your drug in an effective way such that the general public or medical practitioners will choose your drug over other existing treatments. You should choose a ‘snappy’ commercial name for your drug and provide a compelling case to your investors in order to get finance for it. Where possible, this should include looking at the revenue generated by competitors, as well as discussing ways to produce the drug to maximise profits for your investors. This section should end with a brief conclusion that summarises your group’s case for investment.

Answer:

I thought you should know and that is why the introduction the drug venlafaxine will play a great role towards treating the condition. Venlafaxine has proved to be the best medication for depression. This is because the drug acts with speed to relieve the nerves in that within five minutes, the condition is restored back to nomore. This is the best drug for the condition as compared to other drugs which once taken one has to take a sleep for some time so that the condition will be restored back to nomore (Bielski, 2004).

The drug is the best of all because it is a small tablet that tastes sweet. The drug does not have to be taken with water as compared with other drugs that treat the same condition. The tablet can be swallowed any time since it does not cause any side effects as other drugs. When one takes the drug, he or she feels relieved and relaxed at the same time. Moreover, the drug can be taken with food as creates a very sweet aroma when one is taking the food. The drug functions in such a way that it produces some chemicals which give allowance to the brain to work in a normal way. The chemical produced by the drug works towards increasing a level for the messengers which ate sent to the brain hence leading to the restoration of the wellness feeling (O’connor, E 2016, pp.406). 

In marketing the drug, multidisciplinary teams will be used. The teams will have marketing and the planning specialists who will be responsible for educating the public about the drug. The teams will further be divided into subgroups which will be given their drugs for promoting purposes hence enabling further funding. In order to find further breakthrough for the drug, some factors will be considered. First, as the company, there will be learning lessons concerning the drug. This will help when educating the public about the drug. Therefore, clinical experts will be invited to teach more about the condition and how the drug works. They will also teach about an existing competition plus the market need for the drug. To make the marketing process a success, challenges will be examined including the specifics for the drug. To add to that, social media will be involved in promoting and advertising the drug. This will be done through advertisements and the creation of a website that will market the drug. They will also aid in market research so as to help in the planning process plus even decision making. Direct consumer advertisement will also be done in an ethical way. This will help the patients to have a healthy conversation with the medical practitioners in relation to the condition. Television advertisements will also be done.

In terms of making profits, certain strategies must be adopted. This is through having a comparison between the drug and the existing treatments for the condition. The value for the drug will be determined also before setting the price of the drug. This will be done in terms of benefits that will be successfully derived from the patients when a comparison is done with the existing drugs. On the other hand, the investors will take a certain percentage from the sales of the drug so that they will continue investing in the drug (Oliveira, 2004, pp.506).

Lastly, it is quite clear that the drug has great advantages ranging from those who sell the drug to those who take the drug. Therefore, this drug is highly recommended for since it has been proved to be the best of all the drugs that treat the condition of depression.  

Footnotes

Bielski, R.J., 2004. A double-blind contrast of escitalopram and venlafaxine protracted release in the cure of chief depressive illness. The Journal of clinical psychiatry.

Oliveira, de R.A., 2004. The effect of venlafaxine on conduct, body mass and striatal monoamine stages on sleep-deprived feminine rats. Pharmacology Biochemistry and Behavior, 79(3), pp.499-506.

Entsuah, A.R., Huang, 2001. Rejoinder and diminution rates in diverse subpopulations with key depressing disorder overseen venlafaxine, selective serotonin reuptake inhibitors, or placebo. The Journal of clinical psychiatry.

O’connor, E., 2016. Primary overhaul screening for and cure of downheartedness in pregnant and post-delivery women: confirmation report and logical assessment for the US Precautionary Services Task Force. Jama, 315(4), pp.388-406.